Compare BCTXZ & AMPGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCTXZ | AMPGZ |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Telecommunications Equipment |
| Sector | | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2025 | 2012 |
| Metric | BCTXZ | AMPGZ |
|---|---|---|
| Price | $0.14 | $0.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 77.3K | 16.0K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 69.44 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $25,195,930.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 164.99 |
| 52 Week Low | $0.06 | $0.03 |
| 52 Week High | $0.52 | $3.65 |
| Indicator | BCTXZ | AMPGZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.79 | 35.51 |
| Support Level | $0.13 | $0.04 |
| Resistance Level | $0.17 | $0.34 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 37.56 | 22.37 |
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.